Solid Biosciences Inc. (SLDB) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	8.1	13.6	0.0	0.0	0.0	0.0	0.0	4.2
Revenue growth	-40.6%						-100.0%
Cost of goods sold	1.5	0.8	0.0	0.0	0.0	0.0	0.0	6.6
Gross profit	6.6	12.8	0.0	0.0	0.0	0.0	0.0	-2.4
Gross margin	81.8%	94.3%						-56.6%
Selling, general and administrative [+]	114.5	85.9	88.4	24.6	17.7	15.0	5.5	2.4
General and administrative				24.6	17.7	15.0	5.5	2.4
Research and development				94.7	58.0	39.9	20.1
Other operating expenses			-88.4					1.8
EBITDA [+]	-105.5	-70.1	3.9	-116.5	-74.1	-54.4	-25.5
EBITDA growth	50.6%	-1886.5%	-103.4%	57.2%	36.2%	113.2%	288.8%
EBITDA margin	-1303.6%	-514.4%						-156.6%
Depreciation and amortization	2.4	3.0	3.9	2.8	1.6	0.4	0.1
EBIT [+]	-107.9	-73.0	0.0	-119.3	-75.7	-54.9	-25.6	-6.6
EBIT growth	47.8%		-100.0%	57.6%	38.0%	114.5%	289.6%
EBIT margin	-1333.4%	-536.2%						-156.6%
Interest income	2.6	0.1	0.1	1.6	0.6	0.2	0.4	0.0
Interest income	2.6	0.1	0.1	1.6	0.6	0.2	0.4	0.0
Other income (expense), net	105.3	73.0	-0.1	117.7	75.1	1.5	1.4	-0.1
Pre-tax income	0.0	0.0	0.0	0.0	0.0	-53.2	-23.8	-6.7
Income taxes	0.0	0.0	0.0	0.0	0.0	-1.1	-2.2	0.0
Tax rate						2.0%	9.4%	0.0%
Minority interest						-1.1	-2.2	-0.3
Net income	0.0	0.0	0.0	-117.2	-74.8	-39.3	-17.2	-6.7
Net margin	0.0%	0.0%						-159.0%

Basic EPS [+]	$0.00	$0.00	$0.00	($2.91)	($2.25)	($2.88)	($10.14)
Growth			-100.0%	29.4%	-21.9%	-71.6%
Diluted EPS [+]	$0.00	$0.00	$0.00	($2.91)	($2.25)	($2.88)	($10.14)
Growth			-100.0%	29.4%	-21.9%	-71.6%

Shares outstanding (basic) [+]	8.5	7.1	3.5	40.3	33.3	13.6	1.7
Growth	19.6%	105.6%	-91.4%	21.1%	143.7%	703.4%
Shares outstanding (diluted) [+]	8.5	7.1	3.5	40.3	33.3	13.6	1.7
Growth	19.6%	105.6%	-91.4%	21.1%	143.7%	703.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.